The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control

PLoS Medicine

Volumn 13, Issue 4, 2016, Pages

  Lopman, Benjamin A ^a   Steele, Duncan ^b   Kirkwood, Carl D ^b   Parashar, Umesh D ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIARRHEA; ECONOMIC ASPECT; ECONOMIC DEVELOPMENT; FOOD POISONING; GASTROENTERITIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; HUMAN; KNOWLEDGE; NOROVIRUS INFECTION; PUBLIC HEALTH; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; VACCINATION; VIRUS LOAD; WORLD HEALTH ORGANIZATION; ADULT; AGE; CALICIVIRIDAE INFECTIONS; CHILD; DRUG DEVELOPMENT; FOODBORNE DISEASES; GENETICS; GLOBAL HEALTH; IMMUNOLOGY; INCIDENCE; NOROVIRUS; PATHOGENICITY; PREDICTIVE VALUE; PRESCHOOL CHILD; PREVALENCE; PREVENTIVE HEALTH SERVICE; RISK FACTOR; TRANSMISSION; VIROLOGY;

VIRUS VACCINE;

ADULT; AGE FACTORS; CALICIVIRIDAE INFECTIONS; CHILD; CHILD, PRESCHOOL; DIARRHEA; DRUG DISCOVERY; FOODBORNE DISEASES; GASTROENTERITIS; GLOBAL HEALTH; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; NOROVIRUS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; VIRAL VACCINES;

EID: 84964725770     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001999     Document Type: Review

References (44)

1. GBD 2013 Mrtality and Causes of Death CollaboratorsGlobal, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–71. doi: 10.1016/S0140-6736(14)61682-225530442; PubMed Central PMCID: PMCPMC4340604.
2. Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE, et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2015;385(9966):430–40. doi: 10.1016/S0140-6736(14)61698-625280870.
3. Global Health Data Exchange: Institute for Health Metrics and Evaluation; 2013. http://vizhub.healthdata.org/irank/arrow.php.
4. Yen C, Tate JE, Hyde TB, Cortese MM, Lopman BA, Jiang B, et al. Rotavirus vaccines: current status and future considerations. Human vaccines & immunotherapeutics. 2014;10(6):1436–48. doi: 10.4161/hv.2885724755452.
5. Pires SM, Fischer-Walker CL, Lanata CF, Devleesschauwer B, Hall AJ, Kirk MD, et al. Aetiology-Specific Estimates of the Global and Regional Incidence and Mortality of Diarrhoeal Diseases Commonly Transmitted through Food. PLoS ONE. 2015;10(12):e0142927. doi: 10.1371/journal.pone.014292726632843; PubMed Central PMCID: PMCPMC4668836.
6. Platts-Mills JA, Babji S, Bodhidatta L, Gratz J, Haque R, Havt A, et al. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). The Lancet Global health. 2015;3(9):e564–75. doi: 10.1016/S2214-109X(15)00151-526202075.
7. Bucardo F, Reyes Y, Svensson L, Nordgren J, Predominance of norovirus and sapovirus in Nicaragua after implementation of universal rotavirus vaccination. PLoS ONE. 2014;9(5):e98201. doi: 10.1371/journal.pone.009820124849288; PubMed Central PMCID: PMCPMC4029982.
8. Payne DC, Vinje J, Szilagyi PG, Edwards KM, Staat MA, Weinberg GA, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med. 2013;368(12):1121–30. doi: 10.1056/NEJMsa120658923514289; PubMed Central PMCID: PMCPMC4618551.
9. Ahmed SM, Hall AJ, Robinson AE, Verhoef L, Premkumar P, Parashar UD, et al. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(8):725–30. doi: 10.1016/S1473-3099(14)70767-424981041.
10. Kirk MD, Pires SM, Black RE, Caipo M, Crump JA, Devleesschauwer B, et al. World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis. PLoS Med. 2015;12(12):e1001921. doi: 10.1371/journal.pmed.100192126633831; PubMed Central PMCID: PMCPMC4668831.
11. Jones MK, Watanabe M, Zhu S, Graves CL, Keyes LR, Grau KR, et al. Enteric bacteria promote human and mouse norovirus infection of B cells. Science. 2014;346(6210):755–9. doi: 10.1126/science.125714725378626; PubMed Central PMCID: PMCPMC4401463.
12. Baldridge MT, Nice TJ, McCune BT, Yokoyama CC, Kambal A, Wheadon M, et al. Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection. Science. 2015;347(6219):266–9. doi: 10.1126/science.125802525431490; PubMed Central PMCID: PMCPMC4409937.
13. Osborne LC, Monticelli LA, Nice TJ, Sutherland TE, Siracusa MC, Hepworth MR, et al. Coinfection. Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation. Science. 2014;345(6196):578–82. doi: 10.1126/science.125694225082704; PubMed Central PMCID: PMCPMC4548887.
14. Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, et al. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med. 2011;365(23):2178–87. Epub 2011/12/14. doi: 10.1056/NEJMoa110124522150036.
15. Bernstein DI, Atmar RL, Lyon GM, Treanor JJ, Chen WH, Jiang X, et al. Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J Infect Dis. 2015;211(6):870–8. doi: 10.1093/infdis/jiu49725210140.
16. Bartsch SM, Lopman BA, Ozawa S, Hall AJ, Lee BY, Global Economic Burden of Norovirus Gastroenteritis. PLoS ONE. 2016;11(4):e0151219. doi: 10.1371/journal.pone.0151219
17. Mans J, Armah GE, Steele AD, Taylor MB, Norovirus Epidemiology in Africa: A Review. PLoS ONE. 2016;11(4):e0146280. doi: 10.1371/journal.pone.0146280
18. Shioda K, Cosmas L, Audi A, Gregoricus N, Vinjé J, Parashar UD, et al. Population-Based Incidence Rates of Diarrheal Disease Associated with Norovirus, Sapovirus, and Astrovirus in Kenya. PLoS ONE. 2016;11(4):e0145943. doi: 10.1371/journal.pone.0145943
19. Grytdal SP, DeBess E, Lee LE, Blythe D, Ryan P, Biggs C, et al. Incidence of Norovirus and Other Viral Pathogens That Cause Acute Gastroenteritis (AGE) among Kaiser Permanente Member Populations in the United States, 2012–2013. PLoS ONE. 2016;11(4):e0148395. doi: 10.1371/journal.pone.0148395
20. Rha B, Lopman BA, Alcala AN, Riddle MS, Porter CK, Incidence of Norovirus-Associated Medical Encounters among Active Duty United States Military Personnel and Their Dependents. PLoS ONE. 2016;11(4):e0148505. doi: 10.1371/journal.pone.0148505
21. Phillips G, Tam CC, Conti S, Rodrigues LC, Brown D, Iturriza-Gomara M, et al. Community incidence of norovirus-associated infectious intestinal disease in England: improved estimates using viral load for norovirus diagnosis. Am J Epidemiol. 2010;171(9):1014–22. Epub 2010/04/03. doi: 10.1093/aje/kwq02120360244.
22. Verhoef L, Koopmans M, VANP W, Duizer E, Haagsma J, Werber D, et al. The estimated disease burden of norovirus in The Netherlands. Epidemiol Infect. 2013;141(3):496–506. Epub 2012/05/19. doi: 10.1017/S095026881200079922595489.
23. Tam CC, Rodrigues LC, Viviani L, Dodds JP, Evans MR, Hunter PR, et al. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut. 2012;61(1):69–77. doi: 10.1136/gut.2011.23838621708822; PubMed Central PMCID: PMC3230829.
24. Hall AJ, Lopman BA, Payne DC, Patel MM, Gastanaduy PA, Vinje J, et al. Norovirus disease in the United States. Emerg Infect Dis. 2013;19(8):1198–205. doi: 10.3201/eid1908.13046523876403; PubMed Central PMCID: PMCPMC3739528.
25. Allen DJ, Trainor E, Callaghan A, O'Brien SJ, Cunliffe NA, Iturriza-Gómara M, Early Detection of Epidemic GII-4 Norovirus Strains in UK and Malawi: Role of Surveillance of Sporadic Acute Gastroenteritis in Anticipating Global Epidemics. PLoS ONE. 2016;11(4):e0146972. doi: 10.1371/journal.pone.0146972
26. Fumian TM, da Silva Ribeiro de Andrade J, Leite JPG, Miagostovich MP, Norovirus Recombinant Strains Isolated from Gastroenteritis Outbreaks in Southern Brazil, 2004–2011. PLoS ONE. 2016;11(4):e0145391. doi: 10.1371/journal.pone.0145391
27. Lim KL, Hewitt J, Sitabkhan A, Eden J- S, Lun J, Levy A, et al. A Multi-Site Study of Norovirus Molecular Epidemiology in Australia and New Zealand, 2013–2014. PLoS ONE. 2016;11(4):e0145254. doi: 10.1371/journal.pone.0145254
28. Kirby AE, Streby A, Moe CL, Vomiting as a Symptom and Transmission Risk in Norovirus Illness: Evidence from Human Challenge Studies. PLoS ONE. 2016;11(4):e0143759. doi: 10.1371/journal.pone.0143759
29. Ramani S, Estes MK, Atmar RL, Correlates of Protection against Norovirus Infection and Disease—Where Are We Now, Where Do We Go?PLoS Pathog. 12(4): e1005334. doi: 10.1371/journal.ppat.1005334
30. Nordgren J, Sharma S, Kambhampati A, Lopman BA, Svensson L, Innate Resistance and Susceptibility to Norovirus Infection. PLoS Pathog. 12(4): e1005385. doi: 10.1371/journal.ppat.1005385
31. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382(9888):209–22. doi: 10.1016/S0140-6736(13)60844-223680352.
32. Lopman B, Simmons K, Gambhir M, Vinje J, Parashar U, Epidemiologic implications of asymptomatic reinfection: a mathematical modeling study of norovirus. Am J Epidemiol. 2014;179(4):507–12. doi: 10.1093/aje/kwt28724305574.
33. Platts-Mills JA, McCormick BJ, Kosek M, Pan WK, Checkley W, Houpt ER, et al. Methods of analysis of enteropathogen infection in the MAL-ED Cohort Study. Clin Infect Dis. 2014;59Suppl 4:S233–8. doi: 10.1093/cid/ciu40825305292; PubMed Central PMCID: PMCPMC4204610.
34. Vinje J, Advances in laboratory methods for detection and typing of norovirus. J Clin Microbiol. 2015;53(2):373–81. doi: 10.1128/JCM.01535-1424989606; PubMed Central PMCID: PMCPMC4298492.
35. Siebenga JJ, Vennema H, Renckens B, de Bruin E, van der Veer B, Siezen RJ, et al. Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J Virol. 2007;81(18):9932–41. doi: 10.1128/JVI.00674-0717609280; PubMed Central PMCID: PMCPMC2045401.
36. Hoa Tran TN, Trainor E, Nakagomi T, Cunliffe NA, Nakagomi O, Molecular epidemiology of noroviruses associated with acute sporadic gastroenteritis in children: global distribution of genogroups, genotypes and GII.4 variants. J Clin Virol. 2013;56(3):185–93. doi: 10.1016/j.jcv.2012.11.01123218993.
37. Desai R, Hembree CD, Handel A, Matthews JE, Dickey BW, McDonald S, et al. Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clin Infect Dis. 2012;55(2):189–93. doi: 10.1093/cid/cis37222491335; PubMed Central PMCID: PMCPMC3491774.
38. de Graaf M, van Beek J, Vennema H, Podkolzin AT, Hewitt J, Bucardo F, et al. Emergence of a novel GII.17 norovirus—End of the GII.4 era?Euro Surveill. 2015;20(26). 26159308.
39. Baron RC, Greenberg HB, Cukor G, Blacklow NR, Serological responses among teenagers after natural exposure to Norwalk virus. JInfectDis. 1984;150(4):531–4.
40. Johnson PC, Mathewson JJ, DuPont HL, Greenberg HB, Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis. 1990;161(1):18–21. 2153184.
41. Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR, Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med. 1977;297(2):86–9. doi: 10.1056/NEJM197707142970204405590.
42. Wyatt RG, Dolin R, Blacklow NR, DuPont HL, Buscho RF, Thornhill TS, et al. Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis. 1974;129(6):709–14. Epub 1974/06/01. 4209723.
43. Atmar RL, Bernstein DI, Lyon GM, Treanor JJ, Al-Ibrahim MS, Graham DY, et al. Serological Correlates of Protection against a GII.4 Norovirus. Clin Vaccine Immunol. 2015;22(8):923–9. doi: 10.1128/CVI.00196-1526041041; PubMed Central PMCID: PMCPMC4519714.
44. de Wit MA, Koopmans MP, van Duynhoven YT, Risk factors for norovirus, Sapporo-like virus, and group A rotavirus gastroenteritis. Emerg Infect Dis. 2003;9(12):1563–70. doi: 10.3201/eid0912.02007614720397; PubMed Central PMCID: PMCPMC3034344.